首页> 美国卫生研究院文献>Clinical Kidney Journal >Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis
【2h】

Biotin supplement interference with immunoassays for parathyroid hormone and 25-hydroxyvitamin D in a patient with metabolic bone disease on maintenance hemodialysis

机译:生物素补充剂干扰甲状旁腺激素和25-羟基乙多二患者在患者维持血液透析中的患者患者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Biotin (vitamin B7) is a dietary supplement that can lead to falsely abnormal endocrine function tests. The impact of biotin on both 25-hydroxyvitamin D [25(OH)D] and intact parathyroid hormone (iPTH) have not been previously described in end-stage renal disease (ESRD). A woman with ESRD on hemodialysis taking biotin 10 mg daily had a 25(OH)D spike from 25 to >100 ng/mL and an iPTH decrease from 966 to 63 pg/mL. After discontinuation of biotin, her 25(OH)D and iPTH returned to baseline. Biotin can cause erroneous 25(OH)D and iPTH results in ESRD that could adversely affect patient care.
机译:生物素(维生素B7)是一种膳食补充剂,可导致错误异常的内分泌功能测试。生物素对25-羟基维生素D [25(OH)D]和完整的甲状旁腺激素(IPTH)的影响尚未在末期肾病(ESRD)中描述。服用生物素10毫克的血液透析血液透析的妇女每天有25(OH)D穗,从25〜> 100ng / ml,从966到63 pg / ml的IPTH降低。在停止生物素后,她的25(OH)D和IPTH返回基线。生物素可以导致错误的25(OH)D和IPTH导致ESRD,这可能对患者护理产生不利影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号